J Korean Acad Women Health Nurs Search

CLOSE


J Korean Acad Women Health Nurs > Epub ahead of print
Kim, Park, and Ahn: Effects of digital health interventions in women with high-risk pregnancies: a systematic review

Abstract

Purpose

This systematic review evaluated the effectiveness of digital health interventions (DHIs) using technology-based strategies for women with pregnancy complications.

Methods

Six databases were searched: MEDLINE, Embase, Cochrane Library, CINAHL, ProQuest, and Web of Science. The main concepts of interest were (1) target population: women with high-risk pregnancies; (2) health condition: pregnancy complications; (3) interventions: DHIs operationalized via mobile applications, the internet, and text messages; and (4) study design: randomized controlled trials (RCTs). The literature search was performed up to August 31, 2024.

Results

The seven RCTs included in this review were published between 2016 and 2022. These studies originated from three countries: the United Kingdom, Switzerland, and the United States, and involved a total of 5,550 women. Two studies focused on gestational hypertension, four addressed preterm labor, and one dealt with preeclampsia. The interventions were delivered through phone applications or web platforms. While the primary outcomes did not show significant differences between the intervention and control groups across all studies, DHIs demonstrated meaningful secondary outcomes, including reductions in anxiety and stress among high-risk pregnant women.

Conclusion

This review highlights the potential of DHIs to play a vital role in managing high-risk pregnancies. They facilitate early detection and risk prediction of pregnancy complications. Furthermore, digital health tools can markedly reduce stress and anxiety among high-risk pregnant women by providing psychological support. Overall, DHIs present a comprehensive approach to managing physical risks and improving mental well-being in women with high-risk pregnancies.

Introduction

A high-risk pregnancy is defined as any pregnancy with a medical or obstetric condition that may adversely affect maternal or fetal outcomes and threaten the health or life of the mother or her fetus [1]. The complications of high-risk pregnancies include preeclampsia, placental abruption, placenta previa, premature birth, cervical incompetence, postpartum bleeding, amniotic fluid and membrane issues, and gestational diabetes mellitus. These conditions require close monitoring, and women experiencing such complications are often referred to specialized obstetric centers for management [2]. Although specific statistical data on the prevalence of all types of high-risk pregnancies are lacking, the incidence of high-risk complications has risen alongside the increasing average age of women at their first pregnancy [3]. A 2017 report from the Korea Centers for Disease Control and Prevention noted prevalence rates of 5.8% for gestational diabetes mellitus and 1.3% for preeclampsia. Additionally, other studies indicate that approximately 7.7% of births in 2018 were premature [2,4]. High-risk pregnancies account for 6% to 8% of all pregnancies in the United States and South Korea and are a significant concern due to their potential to lead to maternal death [5]. However, timely detection and proper management of high-risk complications can prevent up to 60% of maternal deaths [6,7]. Therefore, rigorous health monitoring during pregnancy is necessary to optimize outcomes for both the mother and the newborn in cases of high-risk pregnancies.
Various interventions have been implemented for different high-risk pregnancy diagnoses. One systematic review compared the effectiveness of these interventions in preventing preterm labor [8]. Another review determined that dietary and lifestyle changes could potentially lower the risk of preeclampsia [9]. Additionally, a meta-analysis indicated that physical activity may protect against the development of gestational diabetes mellitus [10]. However, the accessibility of these interventions is limited in scenarios such as the coronavirus disease 2019 (COVID-19) pandemic and is influenced by economic status, geographic location, and the availability of medical infrastructure for high-risk pregnancies.
Digital health interventions (DHIs) are increasingly utilized across various healthcare sectors. The use of mobile health or digital technologies offers a low-cost, easily accessible method to manage pregnancy complications. DHIs in preventive and personalized healthcare specifically target women with high-risk pregnancies [11]. These interventions provide automated and remote support for self-management, offering users the advantages of flexibility and convenient access to nursing interventions and feedback. In cases of high-risk pregnancy complications, DHIs not only enable women to self-monitor vital health indicators such as blood pressure [12] but also provide internet-based stress management to support psychological well-being during pregnancy [13]. DHIs are particularly promising for pregnant women experiencing preterm labor, who often face mobility restrictions [14,15]. The COVID-19 pandemic has increased the need to provide state-of-the-art interventions and monitoring as long-term support for women with high-risk pregnancies. Pregnant women regularly engage with digital health technologies and have shown a willingness to participate in web-supported perinatal interventions [16]. Previous reviews of high-risk pregnancies have mostly focused on in-person, hospital-based, pharmaceutical interventions [8], with few reviews examining DHIs for women with high-risk pregnancies. This systematic review aims to evaluate the effectiveness of DHIs, which are technology-based strategies designed for women experiencing pregnancy complications.

METHODS

Ethics statement

As this review analyzed existing literature, it was exempt from institutional review board approval.

Study design

The review adheres to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) 2020 guidelines. The study was registered in the PROSPERO (International Prospective Register of Systematic Reviews; No. CRD42022312896) on November 28, 2022.

Literature search methodology and data sources

Two authors conducted independent electronic searches to identify relevant studies, limiting their scope to English articles published in peer-reviewed journals. They searched six databases: MEDLINE, EMBASE, Cochrane Library, CINAHL, ProQuest, and Web of Science. The review focused on four main concepts: (1) target population, specifically women with high-risk pregnancies; (2) health condition, specifically pregnancy complications; (3) intervention, specifically DHI operationalized through mobile applications, the internet, and text messaging; and (4) study design, specifically randomized controlled trials. The review questions were formulated using the PICO-SD (Participants, Intervention, Comparison, Outcome, and Study Design) framework to identify studies that applied DHIs to women with high-risk pregnancies. The search strategy included both keyword and subject heading searches using MeSH and Emtree. The search terms used were: (“eclampsia” OR “preeclampsia” OR “gestational hypertension” OR “premature labor” OR “premature obstetric labor” OR “placenta previa” OR “incompetent cervix” OR “pregnancy complications”) AND (“app” OR “cell phone” OR “digital health” OR “ehealth” OR “email” OR “internet” OR “mhealth” OR “mobile” OR “online” OR “smart phone” OR “sms” OR “technology” OR “text message” OR “web”) AND (“randomized controlled” OR “pilot study”) (Appendix 1). Additionally, manual searches were conducted using Google Scholar to locate relevant studies. There were no restrictions on the publication dates of the studies, and the literature search was conducted up to August 31, 2024. Figure 1 presents a flow chart of the search process for article inclusion in this study.

Inclusion and exclusion criteria

Studies were selected if they met the following criteria:
• Participants: Pregnant women diagnosed with preterm labor, preeclampsia, gestational hypertension, placenta previa, cervix incompetence, or any other condition classified as high-risk pregnancy.
• Intervention: Interventions using all types of digital tools were selected if they were used to manage health conditions during pregnancy, including smartphone applications, internet, and text messages.
• Comparison: Standard of care.
• Outcomes: Maternal/fetal/neonatal outcomes, adverse events, and psychological outcomes.
• Study design: Only randomized controlled trials involving women with high-risk pregnancies were included.
The following types of studies were excluded from this analysis: survey studies, qualitative studies, literature reviews, and studies only reported as abstracts at conferences. Gestational diabetes mellitus was also excluded from consideration, as it has been extensively studied and systematic reviews of DHIs for this condition have already been published [17,18].

Study selection

Relevant studies were first identified independently by two authors (SK, MP). Duplicate articles were removed from the list of studies using EndNote software. The authors thoroughly reviewed the title and abstract of each study to check whether the study met the inclusion criteria. Those two authors independently cross-checked chosen studies that met the criteria. The same two authors then evaluated the full texts of potentially relevant studies. Any disagreements on study selection between the authors were resolved through discussion, and the third author (SA) made the final decisions on the inclusion of those studies.

Data extraction and synthesis

Data extraction was performed by two authors (SK, MP) using a predefined form in Google Sheets to ensure consistency and accuracy. The extracted data encompassed study characteristics (authors, publication year, country), participant characteristics (age range, specific high-risk pregnancy conditions, sample size), details of interventions (technologies, methods), outcomes (primary and secondary), and results. Studies were categorized according to the type of pregnancy complication and the intervention used. A detailed summary of the key findings from each study was prepared, with a focus on the outcomes. The effectiveness of DHIs was evaluated. The characteristics of these DHIs were closely examined, including their main focus, frequency and duration of use, and any reported challenges or facilitators of implementation. This analysis aimed to identify common features of effective interventions. The context in which each study was conducted was analyzed to understand the influence of external factors such as study area and participants' demographics. The synthesis also highlighted gaps in the current literature, and recommendations for future research were formulated based on these gaps.

Quality assessment

We assessed the methodological quality of all included studies using version 2 of the Risk of Bias (RoB 2) tool from the Cochrane Collaboration, which contains five domains of evaluation [19]. Two authors independently assessed the quality of each study. The quality assessment was conducted through consensus between the two authors, with a third author available to resolve any disagreements.

RESULTS

Study characteristics

General and obstetric characteristics of included studies

The initial search yielded 873 studies, from which 292 duplicates were removed. After reviewing the remaining titles and abstracts, 20 studies were selected. Ultimately, seven studies [13-15,20-23] were included in this review. These studies, published between 2016 and 2022, originated from three countries: the United Kingdom, Switzerland, and the United States, and involved a total of 5,550 women. Two of the studies focused on gestational hypertension [20,21], four targeted preterm labor [13-15,23], and one dealt with preeclampsia [22]. All enrolled participants were in their second or third trimester (Table 1).

Type of technology

All studies used one type of technology for the intervention: either a phone application or the web (Table 2). The participants in five studies self-reported their conditions via an application [15,20-23]. Two studies used an internet-based program implemented as a step-by-step module [13,14]. Pregnant women diagnosed with gestational hypertension or preeclampsia were trained to monitor their blood pressure daily at home using a validated automated electronic sphygmomanometer. They transmitted their readings through the Microlife WatchBP Home application (Microlife Corporation, Taipei, Taiwan) supported by a web-based data entry system. The QUantitative Innovation in Predicting Preterm birth (QUiPP) application (developed by Women's Health Academic Centre, King's College London) was employed to manage women experiencing preterm labor, following face-to-face training [15,23]. Women with preterm labor were instructed to attend an internet-based cognitive behavioral stress management (IB-CBSM) program with 6 weeks of online sessions and received feedback after each session [13,14].

The main focus of the intervention

Three studies focused on managing gestational hypertension via self-monitored blood pressure during pregnancy [20-22]. Two studies aimed to reduce levels of anxiety and decisional conflict in participants with preterm labor by allowing clinicians to communicate with them in an easy-to-understand risk-score format in smartphone apps [15,23]. Two studies investigated whether IB-CBSM interventions reduced stress/anxiety and led to better birth outcomes [13,14].

Intervention outcomes

The studies on gestational hypertension primarily relied on daily self-reported blood pressure measurements. Additionally, they monitored maternal, fetal, and neonatal outcomes, adverse events, and psychological factors as secondary outcomes [20-22]. The QUiPP studies utilized a five-page questionnaire booklet to gather demographic and medical information, symptoms, clinical assessments, anxiety scores (Visual Analogue Scale for Anxiety), and decisional conflict scores [15,23]. One IB-CBSM study assessed both physiological indicators, such as birth outcomes and salivary cortisol levels, and psychological indicators, including anxiety, stress, and depression. In contrast, another study focused solely on psychological outcomes, measuring stress, anxiety, satisfaction, and working alliance through self-reported tools [13,14].

Quality assessment of selected studies

The findings of the quality assessment are illustrated in Figure 2. We conducted quality assessments of seven randomized controlled trials using the RoB 2 tool. The bias risk was assessed as low for five of the studies, while two were categorized as having some concerns. These two studies fell into domain 4 (bias in outcome measurement) because participants were aware of their group assignments. A self-reported assessment tool was employed to gauge psychological outcomes, although another study also gathered objective data, including birth outcomes and cortisol levels. The classification of “some concerns” in domain four stemmed from the possibility that knowing the assigned intervention could influence the outcomes reported by participants. However, the impact of this knowledge remains uncertain, as the descriptions of the interventions in the studies were not detailed.

Effectiveness of DHIs

The expected outcomes of the DHIs included lowering blood pressure in studies on gestational hypertension and enhancing early risk detection of preterm labor to improve pregnancy outcomes or decrease the psychological burden during pregnancy in the preterm labor studies. While the primary outcomes did not show significant differences between the intervention and control groups across all studies, the use of digital technology interventions could still offer physiological and psychological benefits for high-risk pregnancies, as indicated by meaningful secondary outcomes in some studies.

Mobile-phone-based intervention: Microlife WatchBP Home application

Three gestational hypertension studies used the Microlife WatchBP Home smartphone application as the intervention [20-22]. There was a high level of persistence in the self-monitoring intervention, with 76% of participants in Tucker et al. [22] and over 80% in Pealing et al. [21] consistently providing home blood pressure readings. The mean systolic blood pressure, the primary outcome, showed no significant differences between the intervention and usual care groups in both the chronic and gestational hypertension categories across all three studies. All three studies reported serious adverse events that were unrelated to the intervention in either the mothers or the infants. Additionally, there were no significant differences in adverse events or maternal/infant outcomes between the intervention and usual care groups. No differences were observed in the mean scores for quality of life and anxiety after the intervention [20-22]. However, participant preferences suggested that home blood pressure monitoring was associated with reduced anxiety [21]. The intervention groups in two of the studies also demonstrated significantly improved scores on the Brief Illness Perception Questionnaire [20,22].

Mobile phone-based intervention: QUiPP application

Two studies on preterm labor provided interventions through mobile phones using the QUiPP application to support women at risk [15,23]. There was a significant reduction in anxiety scores from before to after the intervention. However, no significant reductions in anxiety and decisional conflict were observed in women who knew that the QUiPP application was part of the intervention [23]. Although the management of preterm labor did not differ significantly between the intervention and control sites, unnecessary admissions and discharges could have been reduced at the intervention sites if the QUiPP risk assessment had been properly implemented at the control sites as per the protocol [15]. In cases of adverse outcomes in women with preterm labor, those at the intervention sites more frequently received the management recommended by United Kingdom national guidelines [15]. The QUiPP application, along with its receiver operating characteristic, accurately predicts delivery within 7 days [15].

Internet-based (web-based) intervention: IB-CBSM program

Two studies on preterm labor utilized the IB-CBSM program to support psychological well-being during pregnancy [13,14]. Despite significant reductions in stress and anxiety levels from pre- to posttreatment in both groups, no differences were observed between the groups [13]. Similarly, Urech et al. [14] found no differences in birth outcomes or psychological well-being (depression, anxiety, and stress) between the intervention and control groups, even though psychological well-being improved following both interventions. The intervention group demonstrated significantly higher adherence to the study protocol than the control group. The cortisol awakening response, used as a physiological indicator, showed no significant variations across the groups or over time [14]. Women in the intervention group reported significantly higher satisfaction and Working Alliance Inventory (WAI) scores than those in the control group. Additionally, significant correlations were observed between the Task and Goal subscales of the WAI and levels of stress/anxiety [13].

DISCUSSION

This systematic review aimed to evaluate the effectiveness of DHIs that employ technology-based strategies for women experiencing high-risk pregnancies. Although the primary outcomes showed no significant differences between the intervention and control groups across the studies, DHIs may provide physiological and psychological benefits for high-risk pregnancies, as suggested by several studies with significant secondary outcomes.
According to studies on gestational hypertension, home blood pressure monitoring did not significantly improve blood pressure control compared to usual clinic care. The similar levels of blood pressure control between home and clinic monitoring suggest that monitoring blood pressure at home is as reliable as in the clinic. This interpretation is supported by a previous systematic review, which found no systematic difference between self-monitored and clinic blood pressure readings. This indicates that the appropriate treatment and diagnostic thresholds for self-monitoring should be equivalent to those used in the clinic [24]. Chappell et al. [20] reported that 25% of pregnant participants who had normal blood pressure readings at home but elevated readings in the clinic were experiencing white-coat syndrome. The studies reviewed demonstrated that by avoiding the white-coat effect during pregnancy, DHIs could benefit women with gestational hypertension by allowing them to detect hypertension at home. Furthermore, the absence of significant differences in adverse events and maternal outcomes between the intervention and usual care groups supports the safety of home blood pressure monitoring compared to clinic monitoring. Home blood pressure monitoring can also decrease the frequency of clinic visits and unnecessary hospital admissions for women with gestational hypertension. This not only reduces the financial burden but also provides these women with more rest in the comfort of their home environment, which is crucial for managing high-risk pregnancies.
QUiPP interventions primarily involved healthcare providers who utilized the tool to triage preterm labor. At the control sites, clinicians integrated elements of QUiPP rather than adhering strictly to national guidelines, a factor that may explain the observed lack of impact on reducing unnecessary admissions for preterm labor. Additionally, QUiPP proved highly effective in predicting delivery within 7 days. Notably, a higher number of women experiencing adverse outcomes at the control sites did not receive the recommended management regimen. This finding aligns with those of a previous study [25]. These results provide strong evidence that QUiPP could serve as a valuable guideline for clinical decision-making in cases of preterm labor by accurately forecasting imminent delivery, thereby assisting clinicians and pregnant women in determining the most suitable management approach and timing.
Home blood pressure monitoring was associated with reduced anxiety and improved illness perceptions and was preferred in three studies [20-22]. The QUiPP studies also observed reductions in anxiety and decisional conflict among women with preterm labor, although the mean difference between groups was not statistically significant. In the IB-CBSM studies that provided stress management interventions to women with preterm labor, the intervention group reported in Scherer et al. [13] showed higher satisfaction and working alliance, which significantly correlated with reduced stress/anxiety. Meanwhile, Urech et al. [14] noted reductions in stress/anxiety from pre- to post-intervention in both the intervention and control groups. Psychological well-being is crucial in managing high-risk pregnancies, as psychological factors such as anxiety, stress, and depression are positively associated with increased risks in these pregnancies [26-28]. Although the studies reviewed may not have provided conclusive evidence that DHIs reduce stress or anxiety and enhance psychological well-being, the potential for DHIs to support perinatal mental health care is rapidly increasing [29].
Birth outcomes did not differ significantly between the intervention and control groups in most of the studies, indicating similar levels of infant safety regardless of whether women with high-risk pregnancies received DHIs or usual clinical care.
Intervention persistence/adherence was reported in three studies [14,21,22]. Approximately 80% of the participants maintained adherence to the intervention from enrollment through to delivery, which another study recognized as good adherence [30]. Participants in the IB-CBSM also demonstrated significantly higher adherence compared to those in the control group [21]. High adherence to interventions is essential for achieving desired outcomes, especially since DHIs demand greater participant engagement than those providing human support [31]. These studies, which reported high adherence rates, suggest that DHIs are well-received or even preferred by women with high-risk pregnancies, emphasizing that adherence is crucial for enhancing the effectiveness of interventions.
Information technology usability and accessibility are crucial for the success of DHIs. Programs like the IB-CBSM software require users to be comfortable with computers and web-based platforms, which can significantly influence outcomes, particularly psychological ones. Mobile applications such as Microlife WatchBP Home and QUiPP, used in interventions, must be user-friendly and allow easy access and log in at any time. In this review, we were unable to assess technical issues associated with DHIs, as no problems were reported during the trials. The use of blood pressure monitoring devices may encounter barriers, as identified in a previous study. These include lack of supportive supervision, issues with charging the device, misleading displays, and damage to device components [32]. Another potential barrier is poor communication between clinicians and pregnant women, which is crucial for the effective use of QUiPP. To minimize decisional conflict and anxiety among women experiencing preterm labor, it is essential for them to engage in active discussions with clinicians about QUiPP scores during decision-making processes. Since clinicians are the primary users of the QUiPP app, fostering effective communication is a key challenge in designing DHIs.
This review had some limitations. Since DHIs are relatively new innovations and only randomized controlled trials were selected for this review, only two diagnoses were identified in the seven studies. Regarding DHI methods, the review focused on two phone applications and one web-based program, indicating a lack of diversity in the types of DHIs evaluated. Additionally, there was variability in the outcome measures and the timing of interventions during the pregnancies, which precluded the performance of a meta-analysis to compare effect sizes.
High-quality investigations of digital health necessitate multidisciplinary collaboration from various fields including medicine, science, psychology, education, and engineering [33]. Therefore, conducting and evaluating DHIs to support women with high-risk pregnancies requires insights from a broad range of disciplines, and may benefit from including pregnant women as part of the research team. Another study recommends that designers of DHIs aimed at supporting pregnant women with anxiety should include web-based interactions with therapists, healthcare professionals, and peers [34]. Future research on DHIs should ensure a minimal level of online interaction with healthcare providers to provide reassurance to women experiencing high-risk pregnancies and elevated levels of psychological stress. The current review did not address certain barriers or challenges faced during implementation, such as cost analyses, ease of use, device reliability, data security, and communication with healthcare providers. Future studies should explore and quantify how these and other factors influence effectiveness.
In conclusion, this review highlights the potential of using DHIs to support and monitor women with high-risk pregnancies, to facilitate the early detection or risk predictions of pregnancy complications, and to attenuate stress/anxiety. DHIs ensure patient safety and are as effective as clinic care, thereby reducing the need for frequent clinic visits. This reduction may allow for increased rest in the home environment, a fundamental principle in the management of high-risk pregnancies.

Notes

Authors’ contributions

Conceptualization, Methodology, Formal analysis: Kim S; Investigation: Kim S, Park M; Project administration, Funding acquisition, Validation, Supervision: Ahn S; Software, Data curation, Visualization: Park M; Writing–original draft: Kim S; Writing–review & editing: Kim S.

Conflict of interest

The authors declared no conflict of interest.

Funding

This work was supported by the National Research Foundation of Korea (NRF No. 2020R1A2C201086511).

Data availability

Please contact the corresponding author for data availability.

Figure 1.
PRISMA 2020 flow chart for the literature review. RCT, randomized controlled trial.
whn-2024-12-06f1.jpg
Figure 2.
Assessment of the risk of bias of the included studies.
whn-2024-12-06f2.jpg
Table 1.
Study characteristics of the selected RCTs (N=7)
High-risk pregnancies Study Year Country Participants
Gestational weeks Study outcomes Main findings
Intervention Control
Gestational hypertension Chappell et al. [20] 2022 UK 430 420 20–37 1. Primary outcome: BP 1. Primary outcome
2. Secondary outcomes:  No significant differences between the SMBP group and the usual care group
 1) Psychological: QoL, anxiety, illness perception 2. Secondary outcomes
 2) Maternal and neonatal: serious maternal complications, perinatal outcomes, adverse events  No significant differences in gestational age at birth or infant outcomes
 3) Others: medication adherence  No significant differences in adverse events between the groups
 No significant differences in medication adherence between the groups
 The SMBP group had a lower proportion of spontaneous labor onset than the usual care group (OR, 0.52; 95% CI, 0.29–0.92)
 The SMBP group had higher scores on the modified Brief Illness Perception Questionnaire than the usual care group (p<.001).
Gestational hypertension Pealing et al. [21] 2019 UK 49 23 20–37 1. Primary outcome: BP 1. Primary outcome
2. Secondary outcomes:  No significant differences between the SMBP group and the usual care group
 1) Psychological: QoL, anxiety, medication beliefs 2. Secondary outcomes
 2) Maternal and neonatal: serious maternal complications, perinatal outcomes, adverse events  No significant differences in adverse events, QoL, or anxiety between the groups, although the SMBP group reported lower anxiety and higher control with home monitoring
 3) Others: medication adherence, BP monitoring preference (problem score)  Lower problem score for the SMBP group (MD, –0.7; 95% CI, –0.9 to –0.4)
 High adherence in the SMBP group
Gestational hypertension/preeclampsia Tucker et al. [22] 2022 UK 1,223 1,218 16–24 1. Primary outcome: BP 1. Primary outcome
2. Secondary outcomes:  No significant difference between the SMBP group and the usual care group.
 1) Psychological: QoL, anxiety, illness perception 2. Secondary outcomes
 2) Maternal and neonatal: serious maternal complications, perinatal outcomes, adverse events  No significant differences in the incidence of spontaneous onset of labor, anxiety, and QoL between the groups
 3) Others: medication adherence  The SMBP group had higher scores on the modified Brief Illness Perception Questionnaire than the usual care group (p<.001)
 No significant differences in perinatal outcomes and adverse events between the groups.
 High adherence in the SMBP group
Preterm labor Carlisle et al. [23] 2021 UK 81 121 23–34 1. Primary outcomes: anxiety, decisional conflicts 1. Primary outcomes
 Anxiety levels significantly decreased for women in QUiPP sites, but not statistically significant (t=1.13, p=.26)
 Awareness of using the QUiPP application was associated with lower decisional conflict but without statistical significance (p=.09)
Preterm labor Scherer et al. [13] 2016 Switzerland 51 42 18–32 1. Primary outcomes: stress, anxiety, program satisfaction 1. Primary outcomes
2. Secondary outcome: working alliance  Significant reductions in stress and anxiety levels for both intervention and control groups (p<.001), but no significant differences between the groups
 The intervention group scored significantly higher on patient satisfaction (U=165, p<.001)
2. Secondary outcome
 The intervention group scored significantly higher on working alliance (t=2.476, p=.016)
Preterm labor Urech et al. [14] 2017 Switzerland 50 43 18–32 1. Primary outcomes: anxiety, stress, depression, salivary cortisol level, birth outcome No significant difference in birth outcomes between the IB-CBSM group and the control group.
2. Secondary outcome: adherence to the program Significant improvements in anxiety, depression, and stress over time for both groups (p<.001), but no significant interaction effects between group and time
No significant difference in cortisol awakening responses between groups and time
The IB-CBSM group had significantly higher adherence to the program (p<.001)
Preterm labor Watson et al. [15] 2021 USA 724 1,075 23–34 1. Primary outcome: unnecessary management 1. Primary outcome
2. Secondary outcomes: maternal and neonatal adverse outcomes, process measures  No significant difference in the unnecessary management of TPTL between intervention sites and control sites
 Unnecessary admissions and discharges would have been reduced in the intervention sites if the QUiPP was used as per protocol (7.4% vs. 9.9%) (OR, 0.72; 95% CI, 0.45–1.16)
2. Secondary outcomes
 Maternal adverse outcomes occurred in four patients from the intervention sites and 12 from the control sites without recommended management
 QUiPP was highly predictive of delivery in 7 days (ROC curve, 0.90; 95% CI, 0.85–0.95)

BP: Blood pressure; CI: confidence interval; IB-CBSM: internet-based cognitive behavioral stress management; MD: mean difference; OR: odds ratio; QoL: quality of life; QUiPP: QUantitative Innovation in Predicting Preterm birth; RCT: randomized controlled trial; ROC: receiver operating characteristic; SMBP: self-monitoring blood pressure; TPTL: threatened preterm labor.

Table 2.
Description of the digital health interventions (N=7)
Study Year Technology Intervention title Intervention component details Intervention user Intervention period Intervention management Intervention involvement
Chappell et al. [20] 2022 Application BUMP 2 (using Microlife WatchBP Home) BP monitoring daily Study participants Enrollment to 8 weeks postpartum Clinician BP reading
Text messages Taking 2 readings 1 minute apart, submitting the second reading to the application Midwives Text messages
Getting weekly reminders, motivational messages Audit and follow-up
Pealing et al. [21] 2019 Application OPTIMUM-BP (using Microlife WatchBP Home) BP monitoring daily Study participants Enrollment to 6 weeks postpartum Clinical team BP reading
Text messages Taking 2 readings 1 minute apart, submitting the second reading to the application Study visits
Attending up to three antenatal study visits at 20, 28, and 32 weeks of gestation, a 6-week postnatal face-to-face visit, or telephone study visit
Tucker et al. [22] 2022 Application BUMP 1 (using Microlife WatchBP Home) BP monitoring 3 times per week Study participants Enrollment to postpartum visit Midwives BP reading
Taking 2 readings, submitting a second reading to the application Phone contact
Carlisle et al. [23] 2021 Application QUiPP After the initial face-to-face training, participants were instructed to use the application for 6 weeks without any further face-to-face contact. During this period, two researchers read the comments and wrote free-text annotations Study participants Overall study period: 36 weeks Midwives Training sessions
Scherer et al. [13] 2016 Internet IB-CBSM Six online sessions consisted of psychoeducational information, relaxation exercises, interactive exercises, activity diary, stress and problem-solving protocol Study participants 6 weeks (1 session per week) Psychologist Regular written guidance
Participants received feedback every week and had the opportunity to ask questions about pregnancy to midwives Midwives Weekly feedback
Q&A
Urech et al. [14] 2017 Internet IB-CBSM Six online sessions consisted of psychoeducational information, relaxation training, interactive exercises, emotional training, cognitive training, problem solving and training of enjoyment, and psychoeducation and coping Study participants 6 weeks (1 session per week) Psychologist Weekly feedback via email
Participants received feedback every week
Participants had the opportunity to exchange with others online
Watson et al. [15] 2021 Application QUiPP Receiving face-to-face training on the use of the QUiPP application Clinician Overall study period: 37 weeks Trial team Training the use of the QUiPP application
The clinician assessed pregnant women and inputs info to the application Additional support face-to-face or via email/telephone

BP: blood pressure; BUMP: blood pressure monitoring in pregnancy; IB-CBSM: internet-based cognitive behavioral stress management; QUiPP: QUantitative Innovation in Predicting Preterm birth.

References

1. Queenan JT, Spong CY, Lockwood CJ. Overview of high-risk pregnancy. In: Queenan JT, Spong CY, Lockwood CJ, editors. Management of high-risk pregnancy: an evidence-based approach. 5th ed. Oxford, UK: Wiley-Blackwell; 2007. p. 1-5. https://doi.org/10.1002/9780470691878.ch1

2. Ahn TG, Kim T, Kim Y, Hwang JY. The current state of maternity care and suggestions for improvement in the management of high-risk pregnancies in South Korea. J Korean Soc Matern Child Health. 2018;22(3):134-141. https://doi.org/10.21896/jksmch.2018.22.3.134
crossref
3. Lee JH, Kwon HS, Noh YM, Shin H, Kim T, Lee TH, et al. Perinatal outcomes according to accessibility to maternal-fetal and neonatal intensive care units by region in Korea. J Korean Med Sci. 2022;37(10):e77. https://doi.org/10.3346/jkms.2022.37.e77
crossref pmid
4. Hwang JY. Reclassification of high-risk pregnancy for maternal-fetal healthcare providers. J Korean Soc Matern Child Health. 2020;24(2):65-74. https://doi.org/10.21896/jksmch.2020.24.2.65
crossref
5. University of California, San Francisco (UCSF). High-risk pregnancy overview [Internet]. San Francisco (CA): UCSF Health; 2023 [cited 2023 Jan 20]. Available from: https://www.ucsfhealth.org/conditions/high-risk-pregnancy

6. Zuckerwise LC, Lipkind HS. Maternal early warning systems-towards reducing preventable maternal mortality and severe maternal morbidity through improved clinical surveillance and responsiveness. Semin Perinatol. 2017;41(3):161-165. https://doi.org/10.1053/j.semperi.2017.03.005
crossref pmid
7. Petersen EE, Davis NL, Goodman D, Cox S, Mayes N, Johnston E, et al. Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;68(18):423-429. https://doi.org/10.15585/mmwr.mm6818e1
crossref pmid pmc
8. Care A, Nevitt SJ, Medley N, Donegan S, Good L, Hampson L, et al. Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis. BMJ. 2022;376:e064547. https://doi.org/10.1136/bmj-2021-064547
crossref pmid pmc
9. Allen R, Rogozinska E, Sivarajasingam P, Khan KS, Thangaratinam S. Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: a meta-analysis. Acta Obstet Gynecol Scand. 2014;93(10):973-985. https://doi.org/10.1111/aogs.12467
crossref pmid
10. Russo LM, Nobles C, Ertel KA, Chasan-Taber L, Whitcomb BW. Physical activity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(3):576-582. https://doi.org/10.1097/AOG.0000000000000691
crossref pmid
11. Cummings E, Merolli M, Schaper LK, editors. Digital health: changing the way healthcare is conceptualised and delivered. Selected papers from the 27th Australian National Health Informatics Conference (HIC 2019); August 12-14, 2019; Melbourne, Australia. Amsterdam: IOS Press; 2019.

12. van den Heuvel JF, Teunis CJ, Franx A, Crombag NM, Bekker MN. Home-based telemonitoring versus hospital admission in high risk pregnancies: a qualitative study on women’s experiences. BMC Pregnancy Childbirth. 2020;20(1):77. https://doi.org/10.1186/s12884-020-2779-4
crossref pmid pmc
13. Scherer S, Alder J, Gaab J, Berger T, Ihde K, Urech C. Patient satisfaction and psychological well-being after internet-based cognitive behavioral stress management (IB-CBSM) for women with preterm labor: a randomized controlled trial. J Psychosom Res. 2016;80:37-43. https://doi.org/10.1016/j.jpsychores.2015.10.011
crossref pmid
14. Urech C, Scherer S, Emmenegger M, Gaab J, Tschudin S, Hoesli I, et al. Efficacy of an internet-based cognitive behavioral stress management training in women with idiopathic preterm labor: a randomized controlled intervention study. J Psychosom Res. 2017;103:140-146. https://doi.org/10.1016/j.jpsychores.2017.10.014
crossref pmid
15. Watson HA, Carlisle N, Seed PT, Carter J, Kuhrt K, Tribe RM, et al. Evaluating the use of the QUiPP app and its impact on the management of threatened preterm labour: a cluster randomised trial. PLoS Med. 2021;18(7):e1003689. https://doi.org/10.1371/journal.pmed.1003689
crossref pmid pmc
16. Peragallo Urrutia R, Berger AA, Ivins AA, Beckham AJ, Thorp JM Jr, Nicholson WK. Internet use and access among pregnant women via computer and mobile phone: implications for delivery of perinatal care. JMIR Mhealth Uhealth. 2015;3(1):e25. https://doi.org/10.2196/mhealth.3347
crossref pmid pmc
17. Leblalta B, Kebaili H, Sim R, Lee SW. Digital health interventions for gestational diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials. PLOS Digit Health. 2022;1(2):e0000015. https://doi.org/10.1371/journal.pdig.0000015
crossref pmid pmc
18. Guo P, Chen D, Xu P, Wang X, Zhang W, Mao M, et al. Web-based interventions for pregnant women with gestational diabetes mellitus: systematic review and meta-analysis. J Med Internet Res. 2023;25:e36922. https://doi.org/10.2196/36922
crossref pmid pmc
19. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928
crossref pmid pmc
20. Chappell LC, Tucker KL, Galal U, Yu LM, Campbell H, Rivero-Arias O, et al. Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: The BUMP 2 randomized clinical trial. JAMA. 2022;327(17):1666-1678. https://doi.org/10.1001/jama.2022.4726
crossref pmc
21. Pealing LM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, et al. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: a feasibility trial. Pregnancy Hypertens. 2019;18:141-149. https://doi.org/10.1016/j.preghy.2019.09.018
crossref pmid
22. Tucker KL, Mort S, Yu LM, Campbell H, Rivero-Arias O, Wilson HM, et al. Effect of self-monitoring of blood pressure on diagnosis of hypertension during higher-risk pregnancy: The BUMP 1 randomized clinical trial. JAMA. 2022;327(17):1656-1665. https://doi.org/10.1001/jama.2022.4712
crossref pmid pmc
23. Carlisle N, Watson HA, Seed PT, Carter J, Kuhrt K, Tribe RM, et al. Impact of a medical mobile phone app (QUiPP) for predicting preterm birth on the anxiety and decisional conflicts faced by women in threatened preterm labour. Midwifery. 2021;92:102864. https://doi.org/10.1016/j.midw.2020.102864
crossref pmid
24. Tucker KL, Bankhead C, Hodgkinson J, Roberts N, Stevens R, Heneghan C, et al. How do home and clinic blood pressure readings compare in pregnancy? Hypertension. 2018;72(3):686-694. https://doi.org/10.1161/HYPERTENSIONAHA.118.10917
crossref pmid
25. Watson HA, Carter J, Seed PT, Tribe RM, Shennan AH. The QUiPP app: a safe alternative to a treat-all strategy for threatened preterm labor. Ultrasound Obstet Gynecol. 2017;50(3):342-346. https://doi.org/10.1002/uog.17499
crossref pmid
26. Dayan J, Creveuil C, Herlicoviez M, Herbel C, Baranger E, Savoye C, et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol. 2002;155(4):293-301. https://doi.org/10.1093/aje/155.4.293
crossref pmid
27. Zhang S, Ding Z, Liu H, Chen Z, Wu J, Zhang Y, et al. Association between mental stress and gestational hypertension/preeclampsia: a meta-analysis. Obstet Gynecol Surv. 2013;68(12):825-834. https://doi.org/10.1097/OGX.0000000000000001
crossref pmid
28. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012-1024. https://doi.org/10.1001/archgenpsychiatry.2010.111
crossref pmid pmc
29. Hussain-Shamsy N, Shah A, Vigod SN, Zaheer J, Seto E. Mobile health for perinatal depression and anxiety: scoping review. J Med Internet Res. 2020;22(4):e17011. https://doi.org/10.2196/17011
crossref pmid pmc
30. Vandenberk T, Lanssens D, Storms V, Thijs IM, Bamelis L, Grieten L, et al. Relationship between adherence to remote monitoring and patient characteristics: observational study in women with pregnancy-induced hypertension. JMIR Mhealth Uhealth. 2019;7(8):e12574. https://doi.org/10.2196/12574
crossref pmid pmc
31. Yardley L, Spring BJ, Riper H, Morrison LG, Crane DH, Curtis K, et al. Understanding and promoting effective engagement with digital behavior change interventions. Am J Prev Med. 2016;51(5):833-842. https://doi.org/10.1016/j.amepre.2016.06.015
crossref pmid
32. Vousden N, Lawley E, Nathan HL, Seed PT, Brown A, Muchengwa T, et al. Evaluation of a novel vital sign device to reduce maternal mortality and morbidity in low-resource settings: a mixed method feasibility study for the CRADLE-3 trial. BMC Pregnancy Childbirth. 2018;18(1):115. https://doi.org/10.1186/s12884-018-1737-x
crossref pmid pmc
33. Murray E, Hekler EB, Andersson G, Collins LM, Doherty A, Hollis C, et al. Evaluating digital health interventions: key questions and approaches. Am J Prev Med. 2016;51(5):843-851. https://doi.org/10.1016/j.amepre.2016.06.008
crossref pmid pmc
34. Evans K, Rennick-Egglestone S, Cox S, Kuipers Y, Spiby H. Remotely delivered interventions to support women with symptoms of anxiety in pregnancy: mixed methods systematic review and meta-analysis. J Med Internet Res. 2022;24(2):e28093. https://doi.org/10.2196/28093
crossref pmid pmc

Appendices

Appendix 1.

Search strategy

Database Search term Literature
Cochrane #1 (“eclampsia”):ti,ab,kw 3121 223
#2 (gestational hypertension):ti,ab,kw 2190
#3 (“high risk pregnancy”):ti,ab,kw 687
#4 (“high-risk pregnancies”):ti,ab,kw 324
#5 (“incompetent cervix”):ti,ab,kw 14
#6 (“placenta praevia”):ti,ab,kw 57
#7 (“pre-eclampsia”):ti,ab,kw 2686
#8 (pregnancy complication):ti,ab,kw 4421
#9 (“premature labor”):ti,ab,kw 1739
#10 (“preterm labor”):ti,ab,kw 1702
#11 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 11625
#12 (“APP”):ti,ab,kw 11339
#13 (“cell phone”):ti,ab,kw 1815
#14 (digital health):ti,ab,kw 7318
#15 (ehealth):ti,ab,kw 1841
#16 (internet):ti,ab,kw 16692
#17 (mhealth):ti,ab,kw 2650
#18 (“online”):ti,ab,kw 28117
#19 (smart phone):ti,ab,kw 1476
#20 (text message):ti,ab,kw 3437
#21 (web based):ti,ab,kw 14242
#22 (“technologies”):ti,ab,kw 6617
#23 #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 70871
#24 (“randomized controlled study”):ti,ab,kw 30067
#25 (“randomized control trial”):ti,ab,kw 16966
#26 (“randomized-controlled trial”):ti,ab,kw 677389
#27 (“randomized clinical trial”):ti,ab,kw 71580
#28 (“pilot study”):ti,ab,kw 54418
#29 #24 OR #25 OR #26 OR #27 OR #28 764859
#30 #11 AND #23 AND #29 223
Pubmed (((“eclampsia”[Title/Abstract]) OR (“gestational hypertension”[Title/Abstract]) OR (“high risk pregnancy”[Title/Abstract]) OR (“high risk pregnancies”[Title/Abstract]) OR (“incompetent cervix”[Title/Abstract]) OR (“cervical incompetence”[Title/Abstract]) OR (“placenta previa”[Title/Abstract]) OR (“preeclampsia”[Title/Abstract]) OR (“pregnancy complication”[Title/Abstract]) OR (“premature labor”[Title/Abstract]) OR (“preterm labor”[Title/Abstract]) OR (“uterine cervical incompetence”[Title/Abstract])) AND ((“app”[Title/Abstract]) OR (“apps”[Title/Abstract]) OR (“cell phone”[Title/Abstract]) OR (“digital health”[Title/Abstract]) OR (“ehealth”[Title/Abstract]) OR (“e mail”[Title/Abstract]) OR (“internet”[Title/Abstract]) OR (“mhealth”[Title/Abstract]) OR (“mobile”[Title/Abstract]) OR (“online”[Title/Abstract]) OR (“smart phone”[Title/Abstract]) OR (“sms”[Title/Abstract]) OR (“technology”[Title/Abstract]) OR (“text message”[Title/Abstract]) OR (“web”[Title/Abstract])) AND ((“randomized controlled”[Title/Abstract]) OR (“pilot study”[Title/Abstract]) OR (“randomized control”[Title/Abstract]))) 172
Embase (eclampsia:ti,ab OR “gestational hypertension”:ti,ab OR “high risk pregnancy”:ti,ab OR “high risk pregnancies”:ti,ab OR “incompetent cervix”:ti,ab OR “cervical incompetence”:ti,ab OR “placenta previa”:ti,ab OR preeclampsia:ti,ab OR “pregnancy complication”:ti,ab OR “premature labor”:ti,ab OR “preterm labor”:ti,ab OR “uterine cervical incompetence”:ti,ab) AND (“app”:ti,ab OR “apps”:ti,ab OR “cell phone”:ti,ab OR “digital health”:ti,ab OR ehealth:ti,ab OR “e mail”:ti,ab OR “internet”:ti,ab OR “mhealth”:ti,ab OR “mobile”:ti,ab OR “online”:ti,ab OR “smart phone”:ti,ab OR “sms”:ti,ab OR “technology”:ti,ab OR “text message”:ti,ab OR “web”:ti,ab) AND (“randomized controlled”:ti,ab OR “pilot study”:ti,ab OR “randomized control”:ti,ab) 84
CINAHL AB (eclampsia OR gestational hypertension OR high risk pregnancy OR high risk pregnancies OR incompetent cervix OR placenta previa OR preeclampsia OR pregnancy complication OR premature labor OR preterm labor OR uterine cervical incompetence) AND AB (app OR apps OR cell phone OR digital health OR ehealth OR e mail OR internet OR mhealth OR mobile OR online OR smart phone OR sms OR technology OR text message OR web) AND AB (randomized controlled OR pilot study OR randomized control) 1
Proquest abstract(eclampsia OR gestational hypertension OR high risk pregnancy OR high risk pregnancies OR incompetent cervix OR placenta previa OR preeclampsia OR pregnancy complication OR premature labor OR preterm labor OR uterine cervical incompetence) AND abstract(app OR apps OR cell phone OR digital health OR ehealth OR e mail OR internet OR mhealth OR mobile OR online OR smart phone OR sms OR technology OR text message OR web) AND abstract(randomized controlled OR pilot study OR randomized control) 195
Web of Science TS=((“eclampsia” OR “gestational hypertension” OR “high risk pregnancy” OR “high risk pregnancies” OR “incompetent cervix” OR “cervical incompetence” OR “placenta previa” OR “preeclampsia” OR “pregnancy complication” OR “premature labor” OR “preterm labor” OR “uterine cervical incompetence”) AND (“app” OR “apps” OR “cell phone” OR “digital health” OR “ehealth” OR “e mail” OR “internet” OR “mhealth” OR “mobile” OR “online” OR “smart phone” OR “sms” OR “technology” OR “text message” OR “web”) AND (“randomized controlled” OR “pilot study” OR “randomized control”)) 198


ABOUT
BROWSE ARTICLES
CURRENT ISSUE
FOR AUTHORS AND REVIEWERS
Editorial Office
College of Nursing, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-3276    Fax: +82-2-2227-8303    E-mail: whn@e-whn.org                

Copyright © 2025 by Korean Society of Women Health Nursing.

Developed in M2PI

Close layer
prev next